Bahreyn - İngilizce - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

jaffar pharmacy - tribenoside 5%, lidocaine hcl 2% - cream - 5g+2g/100g

Bahreyn - İngilizce - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

jaffar pharmacy - tribenoside 400mg, lidocaine hcl 40mg - suppository

Suudi Arabistan - İngilizce - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

gulf pharmaceutical industries (julphar), united arab emirates - tribenoside,lidocaine hydrochloride - rectal ointment - 5,2 %,

Birleşik Arap Emirlikleri - İngilizce - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

30 g tube with applicator -

Birleşik Arap Emirlikleri - İngilizce - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

30 g collapsible tube -

Birleşik Arap Emirlikleri - İngilizce - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

julphar drug store l.l.c united arab emirates - 10's [5's blister x 2] - suppository - combination - gastrointestinal system-anal , rectal disorders

Birleşik Arap Emirlikleri - İngilizce - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

julphar drug store l.l.c united arab emirates - 30 g collapsible tube - cream - combination - gastrointestinal system-anal , rectal disorders

Birleşik Arap Emirlikleri - İngilizce - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

julphar drug store l.l.c united arab emirates - 30 g tube with applicator - ointment - combination - gastrointestinal system-anal , rectal disorders

ABD - İngilizce - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - prochlorperazine maleate (unii: i1t8o1jtl6) (prochlorperazine - unii:yhp6ylt61t) - prochlorperazine 5 mg - prochlorperazine maleate tablets are indicated for the control of severe nausea and vomiting. prochlorperazine maleate tablets are also indicated for the treatment of schizophrenia. prochlorperazine is effective for the short-term treatment of generalized non-psychotic anxiety. however, prochlorperazine maleate is not the first drug to be used in therapy for most patients with non-psychotic anxiety, because certain risks associated with its use are not shared by common alternative treatments (e.g., benzodiazepines). when used in the treatment of non-psychotic anxiety, prochlorperazine should not be administered at doses of more than 20 mg per day or for longer than 12 weeks, because the use of prochlorperazine at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible (see warnings). the effectiveness of prochlorperazine as treatment for non-psychotic anxiety was established in 4-week clinical studies of outpatients with generalized anxiety disorder. this evide

ABD - İngilizce - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - chloroprocaine hydrochloride 20 mg in 1 ml - chloroprocaine hydrochloride injection 2% and 3%, in single dose vials, without methylparaben preservative, without edta, is indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. chloroprocaine hydrochloride injection is not to be used for subarachnoid administration. chloroprocaine hydrochloride is contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.